0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-39W17912
Home | Market Reports | Health| Medical Devices & Equipment
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Research Report 2024
BUY CHAPTERS

Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Research Report 2024

Code: QYRE-Auto-39W17912
Report
December 2024
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size

The global market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at US$ 610 million in the year 2023 and is projected to reach a revised size of US$ 885 million by 2030, growing at a CAGR of 5.8% during the forecast period.

Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market

Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market

Chlorhexidine Gluconate (CHG) products for patient skin antisepsis are medical-grade antiseptic product specifically formulated to disinfect and cleanse the skin, thereby reducing the presence of harmful microorganisms. These products are widely used in healthcare settings for various purposes, including preoperative skin preparation and routine patient hygiene.
Chlorhexidine gluconate (CHG) products are specially formulated for disinfection and cleaning of the skin, which can effectively reduce the presence of harmful microorganisms. They are widely used for preoperative skin preparation and routine patient hygiene. Common product types include solutions, washes, wipes, shampoo caps, brushes, applicators, etc.
Chlorhexidine gluconate has a killing effect on Gram-positive and Gram-negative bacteria, facultative anaerobes, aerobic bacteria and yeasts. It is particularly effective against Gram-positive bacteria. With the advent of an aging population, the number of surgeries worldwide has increased year by year. According to statistics, more than 300 million people undergo surgical operations worldwide each year, and surgical site infections (SSIs) and the wounds they cause are also increasing. It refers to nosocomial infections secondary to surgery that occur at or near the surgical incision, deep organs or cavities. It is one of the serious complications after modern surgery and orthopedics, a common cause of unplanned readmissions, and a global problem. SSI patients account for 2% to 5% of hospitalized surgical patients, and the annual incidence rate varies. The number of SSI patients in the United States is 160,000 to 300,000 per year. Studies have shown that chlorhexidine is more advantageous than povidone-iodine in preventing total infection and superficial site infection after potentially contaminated surgery.
With the outbreak of COVID-19, chlorhexidine gluconate ushered in explosive growth in 2020-2021. From a global perspective, Europe and the United States are the core market areas for chlorhexidine gluconate (CHG) products, especially North America, which accounts for 43% of the revenue share, followed by Europe, which accounts for 35% of the market share. The Asia-Pacific region currently mainly uses povidone-iodine for preoperative skin disinfection, but with the continuous expansion of awareness of chlorhexidine gluconate products and the gradual deepening of market promotion, there will be huge market potential in the future.
There are many global players in the chlorhexidine gluconate market, with a wide variety of product types, but most of them are small in scale. The top five manufacturers are mainly European and American companies, namely BD, Ecolab, Stryker, Molnlycke, and Xttrium, which will account for more than 60% of the global market share in 2023. Among them, BD's ChloraPrep applicator products are the world's leading sales, with annual sales exceeding 150 million units. Product types have also gradually evolved from the initial solutions and lotions to wet wipes, gloves, brushes, shampoo caps, etc. Currently, lotions and solution products occupy the core market share.
Chlorhexidine gluconate products are widely used for patient skin disinfection to prevent infection, including hospital-acquired infections (HAIs) and surgical site infections (SSIs). With the increase in demand in surgical and preoperative environments and the increasing awareness of infection prevention, the overall market will continue to expand.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chlorhexidine Gluconate Product for Patient Skin Antisepsis.
The Chlorhexidine Gluconate Product for Patient Skin Antisepsis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chlorhexidine Gluconate Product for Patient Skin Antisepsis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report

Report Metric Details
Report Name Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market
Accounted market size in year US$ 610 million
Forecasted market size in 2030 US$ 885 million
CAGR 5.8%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Operating Theatre
  • Intensive Care Unit
  • General Ward
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BD, Ecolab, Stryker, Molnlycke, Xttrium, 3M, B. Braun, Medichem, GAMA Healthcare, PDI EMEA Ltd., Arion Deutschland GmbH, Medline, CV Médica, Bajaj Medical LLC, SC Johnson Professional, Germo, ACTO GmbH, Lernapharm (LORIS), URGO Sp. z o.o., Welcare Industries, Pearmine Health (Dymacare), Valderma, Innopart Medpro, Raman & Weil Science, Microwin Labs, Weigao Group, Lionser, ShanDong Mint Medical Technology, KINGFA MEDICAL, Shandong Retouch Wash and Sterilize Technology, Liaoning Control Sensory Disinfection Technology, Shandong Disineer Disinfection Science and Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Chlorhexidine Gluconate Product for Patient Skin Antisepsis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Chlorhexidine Gluconate Product for Patient Skin Antisepsis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market growing?

Ans: The Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market witnessing a CAGR of 5.8% during the forecast period 2024-2030.

What is the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market size in 2030?

Ans: The Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market size in 2030 will be US$ 885 million.

What is the BD, Ecolab, Stryker, Molnlycke, Xttrium share in Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market?

Ans: The top five manufacturers are mainly European and American companies, namely BD, Ecolab, Stryker, Molnlycke, and Xttrium, which will account for more than 60% of the global market share in 2023.

Who are the main players in the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market report?

Ans: The main players in the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market are BD, Ecolab, Stryker, Molnlycke, Xttrium, 3M, B. Braun, Medichem, GAMA Healthcare, PDI EMEA Ltd., Arion Deutschland GmbH, Medline, CV Médica, Bajaj Medical LLC, SC Johnson Professional, Germo, ACTO GmbH, Lernapharm (LORIS), URGO Sp. z o.o., Welcare Industries, Pearmine Health (Dymacare), Valderma, Innopart Medpro, Raman & Weil Science, Microwin Labs, Weigao Group, Lionser, ShanDong Mint Medical Technology, KINGFA MEDICAL, Shandong Retouch Wash and Sterilize Technology, Liaoning Control Sensory Disinfection Technology, Shandong Disineer Disinfection Science and Technology

What are the Application segmentation covered in the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market report?

Ans: The Applications covered in the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market report are Operating Theatre, Intensive Care Unit, General Ward, Others

What are the Type segmentation covered in the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market report?

Ans: The Types covered in the Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market report are Antiseptic Wash Lotion & Solution, Antiseptic Wipes & Gloves, Antiseptic Caps, Others

Recommended Reports

Chlorhexidine Markets

Skin Antiseptics

Hospital Disinfection

1 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Overview
1.1 Product Definition
1.2 Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Type
1.2.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Value Comparison by Type (2024-2030)
1.2.2 Antiseptic Wash Lotion & Solution
1.2.3 Antiseptic Wipes & Gloves
1.2.4 Antiseptic Caps
1.2.5 Others
1.3 Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Application
1.3.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Value by Application (2024-2030)
1.3.2 Operating Theatre
1.3.3 Intensive Care Unit
1.3.4 General Ward
1.3.5 Others
1.4 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size Estimates and Forecasts
1.4.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue 2019-2030
1.4.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales 2019-2030
1.4.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Competition by Manufacturers
2.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Product Type & Application
2.7 Global Key Manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Date of Enter into This Industry
2.8 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Competitive Situation and Trends
2.8.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Chlorhexidine Gluconate Product for Patient Skin Antisepsis Players Market Share by Revenue
2.8.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Scenario by Region
3.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region: 2019-2030
3.2.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region: 2019-2024
3.2.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region: 2025-2030
3.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region: 2019-2030
3.3.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region: 2019-2024
3.3.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region: 2025-2030
3.4 North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Facts & Figures by Country
3.4.1 North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2030)
3.4.3 North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Facts & Figures by Country
3.5.1 Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2030)
3.5.3 Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Facts & Figures by Region
3.6.1 Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region (2019-2030)
3.6.3 Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Facts & Figures by Country
3.7.1 Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2030)
3.7.3 Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Facts & Figures by Country
3.8.1 Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Type (2019-2030)
4.1.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Type (2019-2024)
4.1.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Type (2025-2030)
4.1.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Type (2019-2030)
4.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Type (2019-2030)
4.2.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Type (2019-2024)
4.2.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Type (2025-2030)
4.2.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Type (2019-2030)
4.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Application (2019-2030)
5.1.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Application (2019-2024)
5.1.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Application (2025-2030)
5.1.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Application (2019-2030)
5.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Application (2019-2030)
5.2.1 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Application (2019-2024)
5.2.2 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Application (2025-2030)
5.2.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Application (2019-2030)
5.3 Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Ecolab
6.2.1 Ecolab Company Information
6.2.2 Ecolab Description and Business Overview
6.2.3 Ecolab Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ecolab Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.2.5 Ecolab Recent Developments/Updates
6.3 Stryker
6.3.1 Stryker Company Information
6.3.2 Stryker Description and Business Overview
6.3.3 Stryker Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.3.5 Stryker Recent Developments/Updates
6.4 Molnlycke
6.4.1 Molnlycke Company Information
6.4.2 Molnlycke Description and Business Overview
6.4.3 Molnlycke Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Molnlycke Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.4.5 Molnlycke Recent Developments/Updates
6.5 Xttrium
6.5.1 Xttrium Company Information
6.5.2 Xttrium Description and Business Overview
6.5.3 Xttrium Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Xttrium Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.5.5 Xttrium Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 3M Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 B. Braun
6.7.1 B. Braun Company Information
6.7.2 B. Braun Description and Business Overview
6.7.3 B. Braun Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.7.4 B. Braun Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.7.5 B. Braun Recent Developments/Updates
6.8 Medichem
6.8.1 Medichem Company Information
6.8.2 Medichem Description and Business Overview
6.8.3 Medichem Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medichem Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.8.5 Medichem Recent Developments/Updates
6.9 GAMA Healthcare
6.9.1 GAMA Healthcare Company Information
6.9.2 GAMA Healthcare Description and Business Overview
6.9.3 GAMA Healthcare Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GAMA Healthcare Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.9.5 GAMA Healthcare Recent Developments/Updates
6.10 PDI EMEA Ltd.
6.10.1 PDI EMEA Ltd. Company Information
6.10.2 PDI EMEA Ltd. Description and Business Overview
6.10.3 PDI EMEA Ltd. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PDI EMEA Ltd. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.10.5 PDI EMEA Ltd. Recent Developments/Updates
6.11 Arion Deutschland GmbH
6.11.1 Arion Deutschland GmbH Company Information
6.11.2 Arion Deutschland GmbH Description and Business Overview
6.11.3 Arion Deutschland GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Arion Deutschland GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.11.5 Arion Deutschland GmbH Recent Developments/Updates
6.12 Medline
6.12.1 Medline Company Information
6.12.2 Medline Description and Business Overview
6.12.3 Medline Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Medline Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.12.5 Medline Recent Developments/Updates
6.13 CV Médica
6.13.1 CV Médica Company Information
6.13.2 CV Médica Description and Business Overview
6.13.3 CV Médica Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CV Médica Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.13.5 CV Médica Recent Developments/Updates
6.14 Bajaj Medical LLC
6.14.1 Bajaj Medical LLC Company Information
6.14.2 Bajaj Medical LLC Description and Business Overview
6.14.3 Bajaj Medical LLC Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bajaj Medical LLC Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.14.5 Bajaj Medical LLC Recent Developments/Updates
6.15 SC Johnson Professional
6.15.1 SC Johnson Professional Company Information
6.15.2 SC Johnson Professional Description and Business Overview
6.15.3 SC Johnson Professional Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.15.4 SC Johnson Professional Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.15.5 SC Johnson Professional Recent Developments/Updates
6.16 Germo
6.16.1 Germo Company Information
6.16.2 Germo Description and Business Overview
6.16.3 Germo Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Germo Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.16.5 Germo Recent Developments/Updates
6.17 ACTO GmbH
6.17.1 ACTO GmbH Company Information
6.17.2 ACTO GmbH Description and Business Overview
6.17.3 ACTO GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.17.4 ACTO GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.17.5 ACTO GmbH Recent Developments/Updates
6.18 Lernapharm (LORIS)
6.18.1 Lernapharm (LORIS) Company Information
6.18.2 Lernapharm (LORIS) Description and Business Overview
6.18.3 Lernapharm (LORIS) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Lernapharm (LORIS) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.18.5 Lernapharm (LORIS) Recent Developments/Updates
6.19 URGO Sp. z o.o.
6.19.1 URGO Sp. z o.o. Company Information
6.19.2 URGO Sp. z o.o. Description and Business Overview
6.19.3 URGO Sp. z o.o. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.19.4 URGO Sp. z o.o. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.19.5 URGO Sp. z o.o. Recent Developments/Updates
6.20 Welcare Industries
6.20.1 Welcare Industries Company Information
6.20.2 Welcare Industries Description and Business Overview
6.20.3 Welcare Industries Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Welcare Industries Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.20.5 Welcare Industries Recent Developments/Updates
6.21 Pearmine Health (Dymacare)
6.21.1 Pearmine Health (Dymacare) Company Information
6.21.2 Pearmine Health (Dymacare) Description and Business Overview
6.21.3 Pearmine Health (Dymacare) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Pearmine Health (Dymacare) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.21.5 Pearmine Health (Dymacare) Recent Developments/Updates
6.22 Valderma
6.22.1 Valderma Company Information
6.22.2 Valderma Description and Business Overview
6.22.3 Valderma Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Valderma Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.22.5 Valderma Recent Developments/Updates
6.23 Innopart Medpro
6.23.1 Innopart Medpro Company Information
6.23.2 Innopart Medpro Description and Business Overview
6.23.3 Innopart Medpro Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Innopart Medpro Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.23.5 Innopart Medpro Recent Developments/Updates
6.24 Raman & Weil Science
6.24.1 Raman & Weil Science Company Information
6.24.2 Raman & Weil Science Description and Business Overview
6.24.3 Raman & Weil Science Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Raman & Weil Science Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.24.5 Raman & Weil Science Recent Developments/Updates
6.25 Microwin Labs
6.25.1 Microwin Labs Company Information
6.25.2 Microwin Labs Description and Business Overview
6.25.3 Microwin Labs Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Microwin Labs Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.25.5 Microwin Labs Recent Developments/Updates
6.26 Weigao Group
6.26.1 Weigao Group Company Information
6.26.2 Weigao Group Description and Business Overview
6.26.3 Weigao Group Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Weigao Group Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.26.5 Weigao Group Recent Developments/Updates
6.27 Lionser
6.27.1 Lionser Company Information
6.27.2 Lionser Description and Business Overview
6.27.3 Lionser Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Lionser Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.27.5 Lionser Recent Developments/Updates
6.28 ShanDong Mint Medical Technology
6.28.1 ShanDong Mint Medical Technology Company Information
6.28.2 ShanDong Mint Medical Technology Description and Business Overview
6.28.3 ShanDong Mint Medical Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.28.4 ShanDong Mint Medical Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.28.5 ShanDong Mint Medical Technology Recent Developments/Updates
6.29 KINGFA MEDICAL
6.29.1 KINGFA MEDICAL Company Information
6.29.2 KINGFA MEDICAL Description and Business Overview
6.29.3 KINGFA MEDICAL Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.29.4 KINGFA MEDICAL Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.29.5 KINGFA MEDICAL Recent Developments/Updates
6.30 Shandong Retouch Wash and Sterilize Technology
6.30.1 Shandong Retouch Wash and Sterilize Technology Company Information
6.30.2 Shandong Retouch Wash and Sterilize Technology Description and Business Overview
6.30.3 Shandong Retouch Wash and Sterilize Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.30.4 Shandong Retouch Wash and Sterilize Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.30.5 Shandong Retouch Wash and Sterilize Technology Recent Developments/Updates
6.31 Liaoning Control Sensory Disinfection Technology
6.31.1 Liaoning Control Sensory Disinfection Technology Company Information
6.31.2 Liaoning Control Sensory Disinfection Technology Description and Business Overview
6.31.3 Liaoning Control Sensory Disinfection Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.31.4 Liaoning Control Sensory Disinfection Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.31.5 Liaoning Control Sensory Disinfection Technology Recent Developments/Updates
6.32 Shandong Disineer Disinfection Science and Technology
6.32.1 Shandong Disineer Disinfection Science and Technology Company Information
6.32.2 Shandong Disineer Disinfection Science and Technology Description and Business Overview
6.32.3 Shandong Disineer Disinfection Science and Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales, Revenue and Gross Margin (2019-2024)
6.32.4 Shandong Disineer Disinfection Science and Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product Portfolio
6.32.5 Shandong Disineer Disinfection Science and Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Industry Chain Analysis
7.2 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Production Mode & Process
7.4 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales and Marketing
7.4.1 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Channels
7.4.2 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Distributors
7.5 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Customers
8 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Dynamics
8.1 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Industry Trends
8.2 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Drivers
8.3 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Challenges
8.4 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Chlorhexidine Gluconate Product for Patient Skin Antisepsis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Product Type & Application
 Table 12. Global Key Manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chlorhexidine Gluconate Product for Patient Skin Antisepsis as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region (2019-2024) & (K Units)
 Table 18. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Region (2019-2024)
 Table 19. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region (2025-2030) & (K Units)
 Table 20. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Region (2025-2030)
 Table 21. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Region (2019-2024)
 Table 23. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Region (2025-2030)
 Table 25. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2024) & (K Units)
 Table 27. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2025-2030) & (K Units)
 Table 28. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units) by Type (2019-2024)
 Table 51. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units) by Type (2025-2030)
 Table 52. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Type (2019-2024)
 Table 53. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Type (2025-2030)
 Table 54. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Type (2019-2024)
 Table 57. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Type (2025-2030)
 Table 58. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units) by Application (2019-2024)
 Table 61. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units) by Application (2025-2030)
 Table 62. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Application (2019-2024)
 Table 63. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Application (2025-2030)
 Table 64. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Application (2019-2024)
 Table 67. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Application (2025-2030)
 Table 68. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price (US$/Unit) by Application (2025-2030)
 Table 70. BD Company Information
 Table 71. BD Description and Business Overview
 Table 72. BD Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. BD Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 74. BD Recent Developments/Updates
 Table 75. Ecolab Company Information
 Table 76. Ecolab Description and Business Overview
 Table 77. Ecolab Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Ecolab Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 79. Ecolab Recent Developments/Updates
 Table 80. Stryker Company Information
 Table 81. Stryker Description and Business Overview
 Table 82. Stryker Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Stryker Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 84. Stryker Recent Developments/Updates
 Table 85. Molnlycke Company Information
 Table 86. Molnlycke Description and Business Overview
 Table 87. Molnlycke Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Molnlycke Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 89. Molnlycke Recent Developments/Updates
 Table 90. Xttrium Company Information
 Table 91. Xttrium Description and Business Overview
 Table 92. Xttrium Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Xttrium Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 94. Xttrium Recent Developments/Updates
 Table 95. 3M Company Information
 Table 96. 3M Description and Business Overview
 Table 97. 3M Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. 3M Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 99. 3M Recent Developments/Updates
 Table 100. B. Braun Company Information
 Table 101. B. Braun Description and Business Overview
 Table 102. B. Braun Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. B. Braun Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 104. B. Braun Recent Developments/Updates
 Table 105. Medichem Company Information
 Table 106. Medichem Description and Business Overview
 Table 107. Medichem Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Medichem Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 109. Medichem Recent Developments/Updates
 Table 110. GAMA Healthcare Company Information
 Table 111. GAMA Healthcare Description and Business Overview
 Table 112. GAMA Healthcare Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. GAMA Healthcare Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 114. GAMA Healthcare Recent Developments/Updates
 Table 115. PDI EMEA Ltd. Company Information
 Table 116. PDI EMEA Ltd. Description and Business Overview
 Table 117. PDI EMEA Ltd. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. PDI EMEA Ltd. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 119. PDI EMEA Ltd. Recent Developments/Updates
 Table 120. Arion Deutschland GmbH Company Information
 Table 121. Arion Deutschland GmbH Description and Business Overview
 Table 122. Arion Deutschland GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Arion Deutschland GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 124. Arion Deutschland GmbH Recent Developments/Updates
 Table 125. Medline Company Information
 Table 126. Medline Description and Business Overview
 Table 127. Medline Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Medline Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 129. Medline Recent Developments/Updates
 Table 130. CV Médica Company Information
 Table 131. CV Médica Description and Business Overview
 Table 132. CV Médica Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. CV Médica Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 134. CV Médica Recent Developments/Updates
 Table 135. Bajaj Medical LLC Company Information
 Table 136. Bajaj Medical LLC Description and Business Overview
 Table 137. Bajaj Medical LLC Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Bajaj Medical LLC Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 139. Bajaj Medical LLC Recent Developments/Updates
 Table 140. SC Johnson Professional Company Information
 Table 141. SC Johnson Professional Description and Business Overview
 Table 142. SC Johnson Professional Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. SC Johnson Professional Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 144. SC Johnson Professional Recent Developments/Updates
 Table 145. Germo Company Information
 Table 146. Germo Description and Business Overview
 Table 147. Germo Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Germo Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 149. Germo Recent Developments/Updates
 Table 150. ACTO GmbH Company Information
 Table 151. ACTO GmbH Description and Business Overview
 Table 152. ACTO GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. ACTO GmbH Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 154. ACTO GmbH Recent Developments/Updates
 Table 155. Lernapharm (LORIS) Company Information
 Table 156. Lernapharm (LORIS) Description and Business Overview
 Table 157. Lernapharm (LORIS) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Lernapharm (LORIS) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 159. Lernapharm (LORIS) Recent Developments/Updates
 Table 160. URGO Sp. z o.o. Company Information
 Table 161. URGO Sp. z o.o. Description and Business Overview
 Table 162. URGO Sp. z o.o. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. URGO Sp. z o.o. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 164. URGO Sp. z o.o. Recent Developments/Updates
 Table 165. Welcare Industries Company Information
 Table 166. Welcare Industries Description and Business Overview
 Table 167. Welcare Industries Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Welcare Industries Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 169. Welcare Industries Recent Developments/Updates
 Table 170. Pearmine Health (Dymacare) Company Information
 Table 171. Pearmine Health (Dymacare) Description and Business Overview
 Table 172. Pearmine Health (Dymacare) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Pearmine Health (Dymacare) Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 174. Pearmine Health (Dymacare) Recent Developments/Updates
 Table 175. Valderma Company Information
 Table 176. Valderma Description and Business Overview
 Table 177. Valderma Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Valderma Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 179. Valderma Recent Developments/Updates
 Table 180. Innopart Medpro Company Information
 Table 181. Innopart Medpro Description and Business Overview
 Table 182. Innopart Medpro Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Innopart Medpro Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 184. Innopart Medpro Recent Developments/Updates
 Table 185. Raman & Weil Science Company Information
 Table 186. Raman & Weil Science Description and Business Overview
 Table 187. Raman & Weil Science Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. Raman & Weil Science Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 189. Raman & Weil Science Recent Developments/Updates
 Table 190. Microwin Labs Company Information
 Table 191. Microwin Labs Description and Business Overview
 Table 192. Microwin Labs Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 193. Microwin Labs Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 194. Microwin Labs Recent Developments/Updates
 Table 195. Weigao Group Company Information
 Table 196. Weigao Group Description and Business Overview
 Table 197. Weigao Group Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 198. Weigao Group Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 199. Weigao Group Recent Developments/Updates
 Table 200. Lionser Company Information
 Table 201. Lionser Description and Business Overview
 Table 202. Lionser Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 203. Lionser Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 204. Lionser Recent Developments/Updates
 Table 205. ShanDong Mint Medical Technology Company Information
 Table 206. ShanDong Mint Medical Technology Description and Business Overview
 Table 207. ShanDong Mint Medical Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 208. ShanDong Mint Medical Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 209. ShanDong Mint Medical Technology Recent Developments/Updates
 Table 210. KINGFA MEDICAL Company Information
 Table 211. KINGFA MEDICAL Description and Business Overview
 Table 212. KINGFA MEDICAL Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 213. KINGFA MEDICAL Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 214. KINGFA MEDICAL Recent Developments/Updates
 Table 215. Shandong Retouch Wash and Sterilize Technology Company Information
 Table 216. Shandong Retouch Wash and Sterilize Technology Description and Business Overview
 Table 217. Shandong Retouch Wash and Sterilize Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 218. Shandong Retouch Wash and Sterilize Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 219. Shandong Retouch Wash and Sterilize Technology Recent Developments/Updates
 Table 220. Liaoning Control Sensory Disinfection Technology Company Information
 Table 221. Liaoning Control Sensory Disinfection Technology Description and Business Overview
 Table 222. Liaoning Control Sensory Disinfection Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 223. Liaoning Control Sensory Disinfection Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 224. Liaoning Control Sensory Disinfection Technology Recent Developments/Updates
 Table 225. Shandong Disineer Disinfection Science and Technology Company Information
 Table 226. Shandong Disineer Disinfection Science and Technology Description and Business Overview
 Table 227. Shandong Disineer Disinfection Science and Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 228. Shandong Disineer Disinfection Science and Technology Chlorhexidine Gluconate Product for Patient Skin Antisepsis Product
 Table 229. Shandong Disineer Disinfection Science and Technology Recent Developments/Updates
 Table 230. Key Raw Materials Lists
 Table 231. Raw Materials Key Suppliers Lists
 Table 232. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Distributors List
 Table 233. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Customers List
 Table 234. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Trends
 Table 235. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Drivers
 Table 236. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Challenges
 Table 237. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Restraints
 Table 238. Research Programs/Design for This Report
 Table 239. Key Data Information from Secondary Sources
 Table 240. Key Data Information from Primary Sources
 Table 241. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Chlorhexidine Gluconate Product for Patient Skin Antisepsis
 Figure 2. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Share by Type: 2023 & 2030
 Figure 4. Antiseptic Wash Lotion & Solution Product Picture
 Figure 5. Antiseptic Wipes & Gloves Product Picture
 Figure 6. Antiseptic Caps Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Share by Application: 2023 & 2030
 Figure 10. Operating Theatre
 Figure 11. Intensive Care Unit
 Figure 12. General Ward
 Figure 13. Others
 Figure 14. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales (2019-2030) & (K Units)
 Figure 17. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Average Price (US$/Unit) & (2019-2030)
 Figure 18. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Report Years Considered
 Figure 19. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Share by Manufacturers in 2023
 Figure 20. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Chlorhexidine Gluconate Product for Patient Skin Antisepsis Players: Market Share by Revenue in Chlorhexidine Gluconate Product for Patient Skin Antisepsis in 2023
 Figure 22. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Country (2019-2030)
 Figure 25. North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Country (2019-2030)
 Figure 26. United States Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Country (2019-2030)
 Figure 29. Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Region (2019-2030)
 Figure 37. China Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Chlorhexidine Gluconate Product for Patient Skin Antisepsis Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Type (2019-2030)
 Figure 56. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Application (2019-2030)
 Figure 59. Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Price (US$/Unit) by Application (2019-2030)
 Figure 60. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Value Chain
 Figure 61. Chlorhexidine Gluconate Product for Patient Skin Antisepsis Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS